Main > > >CARCINOID SYNDROME. *

Diarrhea. Treat.: Telotristat Ethyl Ta-
blets. 250 mg.+Somatostatin Analogue.
Tryptophan Hydroxylase Inhibition.
EU Approval Date : 2017. 09.19.
USA Approval Date: 2017. 02.28.
(*) Companies; Patents; TradeMark &
Web-Site Available on Request.
UpDate: 2018. 06.18.




Treat.: Lanreotide Acetate Inj.
USA Approval Date: 2017. 09.10.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 11.24.


>CARCINOID SYNDROME. *'s products
This section has no products